8-K: Precision Optics Reports Mixed Fiscal Year 2024 Results with Record Engineering Revenue

Precision Optics Corporation reported a net loss for fiscal year 2024 despite record engineering revenue, with production revenue declining and a significant drop in gross margin.

Summary

• Precision Optics Corporation announced its financial results for the fourth quarter and fiscal year 2024, ending June 30, 2024.
• The company's full-year revenue was $19.1 million, down from $21.0 million in the previous year, but exceeding the high end of the expected range of $18.9 million.
• Production revenue decreased by 25% to $10.8 million, while engineering revenue reached a record $8.3 million, a 24% increase year-over-year.
• Gross margin declined to 30.3% from 36.8% the previous year, which included a one-time sale of technology rights.
• The company reported a net loss of $3.0 million for the year, compared to a net loss of $0.1 million in the previous year.
• Adjusted EBITDA was a loss of $1.6 million, compared to a profit of $0.5 million in the previous fiscal year.
• For the fourth quarter, revenue was $4.7 million, exceeding the implied high end of the range of $4.5 million, but down from $5.0 million in the same quarter of the previous year.
• The company's net loss for the quarter was $1.4 million, compared to a loss of $0.1 million in the same quarter of the previous year.
• Adjusted EBITDA for the quarter was a loss of $1.1 million, compared to a loss of $0.4 million in the same quarter of the previous year.
• The company received a $9 million production order in May 2024 for a single-use cystoscopy surgery program, with production shipments beginning in July 2024.
• In August 2024, the company closed a $1.4 million registered direct offering of common stock.

Sentiment

Score: 4

Explanation: The document presents mixed results with a significant net loss and declining gross margin, offset by record engineering revenue and a large production order. The future outlook is positive but relies on resolving production ramp issues. The sentiment is cautiously optimistic but with significant concerns.

Positives

• Engineering revenue reached a record $8.3 million, demonstrating strong product development capabilities.
• The company exceeded its revenue guidance for both the full year and the fourth quarter.
• A significant $9 million production order was secured, indicating future revenue potential.
• The company successfully completed a $1.4 million capital raise.
• The company anticipates double-digit revenue growth in fiscal year 2025.

Negatives

• Full-year revenue decreased to $19.1 million from $21.0 million in the previous year.
• Production revenue decreased by 25% to $10.8 million.
• Gross margin declined to 30.3% from 36.8% in the previous year.
• The company reported a net loss of $3.0 million for the year, a significant increase from the $0.1 million loss in the previous year.
• Adjusted EBITDA was a loss of $1.6 million, compared to a profit of $0.5 million in the previous fiscal year.
• The fourth quarter also saw a net loss of $1.4 million, compared to a loss of $0.1 million in the same quarter of the previous year.

Risks

• The company experienced a significant decrease in production revenue, which could impact future profitability.
• The decline in gross margin indicates potential challenges in cost management or pricing.
• The company's net loss has increased substantially year-over-year, raising concerns about financial stability.
• The company is facing challenges in the start-up and ramp of key production programs, which impacted first quarter revenue.

Future Outlook

The company expects first quarter revenue for fiscal year 2025 to be in the range of $4.2 to $4.4 million, relatively flat compared to the previous year's first quarter. They anticipate double-digit revenue growth for fiscal 2025, with significant increases beginning in the second quarter.

Management Comments

• Upon exiting fiscal 2023, we were facing the loss of several significant programs that would not be continuing in fiscal 2024, totaling more than $7 million in annualized revenue.
• Due to the strength of our engineering pipeline, we backfilled a significant portion of the shortfall with record levels of product development revenue coupled with new products entering production.
• Currently several programs are transitioning from the development phase to production, including the program associated with the $9 million purchase order we announced in May.
• We have now reached a new phase for the Company, with a sizeable and growing base of production programs and product development revenue continuing at the record levels we achieved last year.
• We expect our first quarter revenue will be in the range of $4.2 to $4.4 million, relatively flat compared to the previous years first quarter.
• Revenue for the first quarter was impacted by certain challenges in the start-up and ramp of key production programs.
• These issues are mostly now resolved, and with the growth of production and ongoing strong product development sales, we expect double digit revenue growth for fiscal 2025 with significant increases in revenue beginning with the second quarter of fiscal 2025.

Industry Context

Precision Optics operates in the medical and defense/aerospace industries, which are characterized by high technological requirements and stringent quality standards. The company's focus on micro-optics and 3D imaging aligns with the increasing demand for minimally invasive surgical tools and advanced defense applications. The company's ability to secure a large production order in the medical field is a positive sign, but the overall financial results indicate challenges in scaling production and maintaining profitability.

Comparison to Industry Standards

• Comparing Precision Optics to similar companies in the optics and medical device manufacturing space, such as those involved in endoscope production or specialized optical components, reveals a mixed performance.
• While companies like Olympus or Stryker, which are much larger, have established production and distribution networks, Precision Optics is still in a growth phase, focusing on engineering and new product development.
• The 25% decrease in production revenue is concerning when compared to companies that have stable production volumes, but the 24% increase in engineering revenue is a positive sign of future potential.
• The gross margin of 30.3% is lower than some established players in the industry, which often have margins above 40%, indicating a need for Precision Optics to improve cost management or pricing strategies.
• The net loss of $3.0 million is a significant concern, especially when compared to companies that are profitable or have smaller losses, suggesting that Precision Optics needs to focus on scaling production and improving profitability.

Stakeholder Impact

• Shareholders will be concerned about the increased net loss and decreased gross margin.
• Employees may be impacted by the company's efforts to improve production efficiency.
• Customers may benefit from the company's new products and increased production capacity.
• Suppliers may see increased demand as production ramps up.
• Creditors will be monitoring the company's financial performance closely.

Next Steps

• The company will focus on resolving the challenges in the start-up and ramp of key production programs.
• The company will work to scale production and improve profitability.
• The company expects double-digit revenue growth for fiscal 2025, with significant increases beginning in the second quarter.

Key Dates

Keywords

Precision Optics, Financial Results, Engineering Revenue, Production Revenue, Gross Margin, Net Loss, Adjusted EBITDA, Medical Devices, Defense, Aerospace, Capital Raise